Myocardial Solutions, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$19Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
72clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $514
2021 $1,415
2022 $5,043
2023 $3,147
2024 $4,164
2025 $5,000

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Medical Oncology $11K
Advanced Heart Failure and Transplant Cardiology $5,192
Cardiovascular Disease $880
Interventional Cardiology $477
Internal Medicine $373
Family Medicine $204

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Susan Dent Rochester, NY Medical Oncology $11,293.58
John Jefferies Memphis, TN Advanced Heart Failure and Transplant Cardiology $5,028.37
Juan Lopez-Mattei Fort Myers, FL Cardiovascular Disease $191.66
Jeffrey Moses New York, NY Interventional Cardiology $172.99
Juan Plana Gomez Houston, TX Cardiovascular Disease $157.84
Jillian Chamberlain Houston, TX Physician Assistant $147.92
Imran Dar Houston, TX Interventional Cardiology $134.72
Nestor Zenarosa Dallas, TX Emergency Medicine $105.00
Daniel Lenihan Texas City, TX Advanced Heart Failure and Transplant Cardiology $100.49
Joshua Mitchell Saint Louis, MO Cardiovascular Disease $100.49

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.